Aegis Sciences Announces CDC Contract to Provide Genomic Sequencing of SARS-CoV-2 to Aid Public Health Response to COVID-19
16 mars 2021 09h00 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn., March 16, 2021 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative COVID-19 and medication compliance testing services,...
Aegis Sciences Corporation announces it has been awarded $6.6 million NIH grant to rapidly expand COVID-19 Test Capacity
02 sept. 2020 11h05 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting...
Aegis Sciences Corporation Announces National Launch of COVID-19 Antibody Testing Utilizing Convenient Dry Blood Spot Technology
31 août 2020 10h30 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
WPD Pharmaceuticals Announces FDA Application Under The Orphan Drug Act Was Submitted By License Partner for Brain Cancer Drug, Berubicin
24 avr. 2020 03h05 HE
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company is pleased to...
WPD Pharmaceuticals Partners with CNS Pharmaceuticals on Drug Development for Coronavirus and Other Antiviral Indications
24 mars 2020 03h05 HE
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, March 24, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company, announces it has...
WPD Pharmaceuticals' STAT3 Inhibitor Received FDA Approval of IND Status in Pediatric Brain Cancer Trial
20 févr. 2020 03h05 HE
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, Feb. 20, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company is pleased to provide...
CURE Pharmaceutical [OTCQB: CURR] Takes First Step To Secure Hemp CBD Supply Chain by Partnering with Fytiko Farms
21 août 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has signed a deal with Oklahoma-based hemp...
CURE Pharmaceutical Expands Board with Two Women Directors
07 août 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the addition of two directors to its Board,...
CURE Pharmaceutical [OTCQB:CURR] Secures Patent on High Loading of Active Ingredient in Oral Thin Films
24 juil. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No....
CURE Pharmaceutical [OTCQB:CURR] Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients
16 juil. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No....